Clinical studies recruiting near Stuttgart

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Klinikum Der Landeshauptstadt Stuttgart gKAöR · Princess Maxima Center for Pediatric Oncology · NCT05327894 Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
Phase 3 · Klinikum Stuttgart · AGO Study Group · NCT05009082 Evaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve Insufficiency on Renal Int
Phase N/A · Robert Bosch Hospital · Robert Bosch Medical Center · NCT07464106 Randomization of Single vs Multiple Arterial Grafts
NA · Robert-Bosch-Hospital · Weill Medical College of Cornell University · NCT03217006 Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma
Phase 3 · ROBERT BOSCH KRANKENHAUS - Hämatologie, Onkologie und Pallia · The Lymphoma Academic Research Organisation · NCT06006117 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Robert Bosch Krankenhaus GmbH · Eli Lilly and Company · NCT06890598 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Robert-Bosch-Krankenhaus · Regeneron Pharmaceuticals · NCT06091865 International HIT-MED Registry (I-HIT-MED)
Phase N/A · Klinikum Stuttgart · Universitätsklinikum Hamburg-Eppendorf · NCT02417324 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Robert-Bosch-Krankenhaus · Pfizer · NCT07144280 PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS
Phase N/A · Diakonieklinikum Stuttgart, Brustzetrum · Women's Cancer Study Group GmbH · NCT05792150 GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of
Phase N/A · Diakonie-Klinikum Stuttgart · Goethe University · NCT02872987 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Robert-Bosch-Krankenhaus GmbH · Boehringer Ingelheim · NCT06531824 A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Phase 2 · Klinikum Stuttgart - Katharinenhospital ( Site 0909) · Merck Sharp & Dohme LLC · NCT06833073 Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy
Phase 4 · Robert-Bosch-Krankenhaus (RBK) Stuttgart; Gastroenterologie, · University of Leipzig · NCT05551299 Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06517719 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Robert-Bosch-Krankenhaus ( Site 1401) · Merck Sharp & Dohme LLC · NCT06623422 A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Katharinenhospital Innere Medizin · Janssen Research & Development, LLC · NCT06319820 Safety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atrophy
NA · Department of Ophthalmology, Klinikum Stuttgart · Okuvision GmbH · NCT07531927 Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML
Phase 2 · Robert-Bosch-Krankenhaus · Technische Universität Dresden · NCT05904106 Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNS
Phase 3 · Klinikum Stuttgart, Clinic of Hematology, Oncology and Palli · University Hospital Freiburg · NCT06830421 A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-
Phase 2 · Klinikum Stuttgart. Klinik fur Hamatologie. Onkologie. Palli · Merck Sharp & Dohme LLC · NCT06890884 A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06830720 A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgic
NA · Robert Bosch Hospital · Vascutek Ltd. · NCT07078383 Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Le
Phase 2 · Robert-Bosch-Krankenhaus; Abteilung für Hämatologie, Onkolog · Goethe University · NCT06648889 Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma
Phase 3 · Klinikum der Landeshauptstadt Stuttgart - Katharinenhospital · University of Heidelberg Medical Center · NCT06216158 International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Phase 3 · Klinikum Stuttgart, Olgahospital Zentrum für Kinder- und Jug · University Hospital Muenster · NCT04043494 Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic N
Phase 3 · Research Site · AstraZeneca · NCT07291037 Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
Phase 3 · Olga-Hospital, Kinderklinik, Pädiatrisches Zentrum, Abt. Häm · Martin Schrappe · NCT03643276

Look up another city

Look up another condition